\-\ Texto\\:\\ \ \(0\)\
\-\ mild\\ flank\\ pain\\.\\ microhematuria\\,\\ with\\ creatinine\\ of\\ 2\\.0\\.\\ remaining\\ labs\\ normal\\.\ \(0\)\
\-\ treated\\ with\\ a\\ mixture\\ of\\ sodium\\ and\\ potassium\\ bicarbonate\\,\\ constant\\ hydration\\.\ \(0\)\
\-\ severe\\ bilateral\\ medullary\\ nephrocalcinosis\ \(0\)\
\-\ renal\\ tubular\\ acidosis\\,\\ medullary\\ nephrocalcinosis\ \(0\)\
\-\ the\\ primary\\ differential\\ covering\\ the\\ majority\\ of\\ cases\\:\ \(0\)\
\-\ 1\\.\\	hyperparathyroidism\ \(0\)\
\-\ 2\\.\\	renal\\ tubular\\ acidosis\ \(0\)\
\-\ 3\\.\\	medullary\\ sponge\\ kidney\ \(0\)\
\-\ an\\ exhaustive\\ differential\\ includes\\â\\€\\¦\\.\ \(0\)\
\-\ hypercalciuria\\:\\ hyperparathyroidism\ \(0\)\
\-\ \\	paraneoplastic\\ syndrome\\ of\\ lung\\ and\\ renal\\ primaries\ \(0\)\
\-\ \\	cushings\\ syndrome\ \(0\)\
\-\ \\	diabetes\\ insipidis\ \(0\)\
\-\ \\	hyper\\ or\\ hypothyroidism\ \(0\)\
\-\ alimentary\\:\\ mild\\-alkali\\ syndrome\ \(0\)\
\-\ \\	hypervitaminosis\\ d\ \(0\)\
\-\ \\	beryllium\\ poisoning\ \(0\)\
\-\ osseous\\:\\ osseous\\ mets\\,\\ multiple\\ myeloma\ \(0\)\
\-\ \\	porlonged\\ immobilization\ \(0\)\
\-\ \\	progessive\\ senile\\ osteoporosis\ \(0\)\
\-\ renal\\:\\	medullary\\ sponge\\ kidney\ \(0\)\
\-\ \\	renal\\ tubular\\ acidosis\ \(0\)\
\-\ \\	barter\\ syndrome\ \(0\)\
\-\ drugs\\:\\	furosemide\\ in\\ infants\ \(0\)\
\-\ \\	prolonged\\ acth\\ therapy\ \(0\)\
\-\ \\	excess\\ vitamin\\ e\\,\\ d\\ or\\ calcium\ \(0\)\
\-\ \\	nephrotoxic\\ drugs\\ such\\ as\\ amphotericin\\ b\ \(0\)\
\-\ miscellaneous\ \(1\)\
\-\ \\	sarcoidosis\ \(0\)\
\-\ \\	idiopathic\\ hypercalciuria\\ or\\ hypercalcemia\ \(0\)\
\-\ 35\\ year\\ old\\ white\\ male\\ with\\ flank\\ pain\\.\\ patient\\ has\\ history\\ of\\ frequent\\ stone\\ passage\\,\\ sometimes\\ as\\ frequently\\ as\\ every\\ other\\ day\ \(0\)\
\-\ with\\ treatment\\,\\ the\\ patient\\ noted\\ a\\ decrease\\ in\\ the\\ number\\ of\\ stones\\ he\\ would\\ pass\\,\\ from\\ 2\\-3\\ a\\ day\\,\\ down\\ to\\ 1\\ every\\ week\\ or\\ two\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ acidosis\\:\\ 0\\.08761399298352648\ \(0\)\
\-\ medullary\\:\\ 0\\.08689922164347437\ \(0\)\
\-\ hypercalciuria\\:\\ 0\\.07861612764917045\ \(0\)\
\-\ renal\\:\\ 0\\.0679226335835468\ \(0\)\
\-\ nephrocalcinosis\\:\\ 0\\.06330481566042626\ \(0\)\
\-\ sponge\\:\\ 0\\.06330481566042626\ \(0\)\
\-\ tubular\\:\\ 0\\.06316248439706382\ \(0\)\
\-\ syndrome\\:\\ 0\\.051722890512902464\ \(0\)\
\-\ drugs\\:\\ 0\\.04995951176449098\ \(0\)\
\-\ every\\:\\ 0\\.048030183121168704\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.04745804321354674\ \(0\)\
\-\ includes\\â\\€\\¦\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ insipidis\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ mild\\-alkali\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ beryllium\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ porlonged\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ senile\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ barter\\:\\ 0\\.04664295462416136\ \(0\)\
\-\ d\\:\\ 0\\.045096735792232355\ \(0\)\
\-\ exhaustive\\:\\ 0\\.04297550922437329\ \(0\)\
\-\ progessive\\:\\ 0\\.04297550922437329\ \(0\)\
\-\ flank\\:\\ 0\\.04253680294571171\ \(0\)\
\-\ alimentary\\:\\ 0\\.040830191192054964\ \(0\)\
\-\ cushings\\:\\ 0\\.039308063824585224\ \(0\)\
\-\ nephrotoxic\\:\\ 0\\.039308063824585224\ \(0\)\
\-\ osseous\\:\\ 0\\.03839293775794437\ \(0\)\
\-\ 2\\.0\\.\\:\\ 0\\.03812741011392803\ \(0\)\
\-\ bicarbonate\\:\\ 0\\.03812741011392803\ \(0\)\
\-\ primaries\\:\\ 0\\.03812741011392803\ \(0\)\
\-\ miscellaneous\\:\\ 0\\.03812741011392803\ \(0\)\
\-\ hypervitaminosis\\:\\ 0\\.037162745792266895\ \(0\)\
\-\ \\:\\:\\ 0\\.03588174019017984\ \(0\)\
\-\ furosemide\\:\\ 0\\.035640618424797155\ \(0\)\
\-\ acth\\:\\ 0\\.03445996471413996\ \(0\)\
\-\ amphotericin\\:\\ 0\\.03349530039247882\ \(0\)\
\-\ microhematuria\\:\\ 0\\.03307179400267175\ \(0\)\
\-\ paraneoplastic\\:\\ 0\\.03267968832990074\ \(0\)\
\-\ hyper\\:\\ 0\\.03231464668182163\ \(0\)\
\-\ poisoning\\:\\ 0\\.03231464668182163\ \(0\)\
\-\ covering\\:\\ 0\\.03197317302500908\ \(0\)\
\-\ kidney\\:\\ 0\\.03185590957724878\ \(0\)\
\-\ potassium\\:\\ 0\\.03165240783021313\ \(0\)\
\-\ hydration\\:\\ 0\\.031063912406349512\ \(0\)\
\-\ mixture\\:\\ 0\\.030792519314351886\ \(0\)\
\-\ excess\\:\\ 0\\.03028823264872054\ \(0\)\
\-\ hypercalcemia\\:\\ 0\\.03028823264872054\ \(0\)\
\-\ sodium\\:\\ 0\\.03005303813776375\ \(0\)\
\-\ differential\\:\\ 0\\.028708569622782322\ \(0\)\
\-\ day\\:\\ 0\\.028708569622782322\ \(0\)\
\-\ passage\\:\\ 0\\.02814291461640221\ \(0\)\
\-\ constant\\:\\ 0\\.02753756884297499\ \(0\)\
\-\ osteoporosis\\:\\ 0\\.02739646700656144\ \(0\)\
\-\ e\\:\\ 0\\.026866924897794336\ \(0\)\
\-\ vitamin\\:\\ 0\\.02662078724893247\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.026501883249715228\ \(0\)\
\-\ myeloma\\:\\ 0\\.026271803292362114\ \(0\)\
\-\ infants\\:\\ 0\\.026271803292362114\ \(0\)\
\-\ mets\\:\\ 0\\.02605131283521625\ \(0\)\
\-\ pass\\:\\ 0\\.02605131283521625\ \(0\)\
\-\ creatinine\\:\\ 0\\.025736903203095608\ \(0\)\
\-\ 2\\-3\\:\\ 0\\.02439590372791287\ \(0\)\
\-\ immobilization\\:\\ 0\\.02431751703063699\ \(0\)\
\-\ prolonged\\:\\ 0\\.024015091560584352\ \(0\)\
\-\ remaining\\:\\ 0\\.02352418291798665\ \(0\)\
\-\ stones\\:\\ 0\\.023262845588200527\ \(0\)\
\-\ sometimes\\:\\ 0\\.023013811139216477\ \(0\)\
\-\ frequent\\:\\ 0\\.022604357892574044\ \(0\)\
\-\ number\\:\\ 0\\.022548367896116178\ \(0\)\
\-\ stone\\:\\ 0\\.022492964193114615\ \(0\)\
\-\ diabetes\\:\\ 0\\.022383867435428178\ \(0\)\
\-\ majority\\:\\ 0\\.022224327550927188\ \(0\)\
\-\ calcium\\:\\ 0\\.022120579025062762\ \(0\)\
\-\ b\\:\\ 0\\.02131231048245742\ \(0\)\
\-\ or\\:\\ 0\\.02119624865531656\ \(0\)\
\-\ 35\\:\\ 0\\.02080802381682607\ \(0\)\
\-\ decrease\\:\\ 0\\.020689119817608827\ \(0\)\
\-\ idiopathic\\:\\ 0\\.020611309513959647\ \(0\)\
\-\ as\\:\\ 0\\.020517103268160756\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.020421647441085912\ \(0\)\
\-\ frequently\\:\\ 0\\.019595400188412458\ \(0\)\
\-\ down\\:\\ 0\\.019407534111920872\ \(0\)\
\-\ would\\:\\ 0\\.01608977184350312\ \(0\)\
\-\ labs\\:\\ 0\\.01572473019542401\ \(0\)\
\-\ 3\\.\\:\\ 0\\.015470233926670515\ \(0\)\
\-\ week\\:\\ 0\\.015354578932953587\ \(0\)\
\-\ cases\\:\\ 0\\.015062491343815515\ \(0\)\
\-\ white\\:\\ 0\\.01499526038471967\ \(0\)\
\-\ 2\\.\\:\\ 0\\.014378011332276498\ \(0\)\
\-\ such\\:\\ 0\\.014134035925083874\ \(0\)\
\-\ 1\\.\\:\\ 0\\.014122694001574607\ \(0\)\
\-\ severe\\:\\ 0\\.013911692063841291\ \(0\)\
\-\ treated\\:\\ 0\\.013533602307322005\ \(0\)\
\-\ primary\\:\\ 0\\.013393567528548658\ \(0\)\
\-\ lung\\:\\ 0\\.013096080001263206\ \(0\)\
\-\ two\\:\\ 0\\.012948842527068813\ \(0\)\
\-\ \\,\\:\\ 0\\.012890955500823208\ \(0\)\
\-\ he\\:\\ 0\\.012614747841444547\ \(0\)\
\-\ therapy\\:\\ 0\\.012088046540955624\ \(0\)\
\-\ mild\\:\\ 0\\.011906102930852576\ \(0\)\
\-\ pain\\:\\ 0\\.011043472672282907\ \(0\)\
\-\ bilateral\\:\\ 0\\.0109725805783833\ \(0\)\
\-\ 1\\:\\ 0\\.01075834057121538\ \(0\)\
\-\ noted\\:\\ 0\\.010716514224616898\ \(0\)\
\-\ other\\:\\ 0\\.010421367982552637\ \(0\)\
\-\ multiple\\:\\ 0\\.009522783087191898\ \(0\)\
\-\ treatment\\:\\ 0\\.009151412484660778\ \(0\)\
\-\ patient\\:\\ 0\\.009064464877422095\ \(0\)\
\-\ has\\:\\ 0\\.008490476034361259\ \(0\)\
\-\ male\\:\\ 0\\.008175690676653297\ \(0\)\
\-\ normal\\:\\ 0\\.007087896585180428\ \(0\)\
\-\ from\\:\\ 0\\.006700718059016996\ \(0\)\
\-\ a\\:\\ 0\\.006295234949501607\ \(0\)\
\-\ an\\:\\ 0\\.006252195049125555\ \(0\)\
\-\ history\\:\\ 0\\.006244521363529542\ \(0\)\
\-\ year\\:\\ 0\\.00505875803848103\ \(0\)\
\-\ old\\:\\ 0\\.00462928358128177\ \(0\)\
\-\ in\\:\\ 0\\.004459229948574126\ \(0\)\
\-\ of\\:\\ 0\\.0036985333586662993\ \(0\)\
\-\ the\\:\\ 0\\.0029259107873783234\ \(0\)\
\-\ with\\:\\ 0\\.002476278859045285\ \(0\)\
\-\ to\\:\\ 0\\.0022596196213914618\ \(0\)\
\-\ and\\:\\ 0\\.001904857203515539\ \(0\)\
\-\ \\.\\:\\ 0\\.0011269693999157546\ \(0\)\
